Company Name:Immunomedics Inc.
CEO:

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Immunomedics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.





2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30,
2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30,
2016-06-30, 2017-06-30, 2018-06-30, 2018-12-31,
2016-06-30, 2017-06-30, 2018-06-30, 2018-12-31,